Author: FX

The Euro trims gains after failure at the 0.8860 resistance area. The Pound appreciates across the board amid a softer USD. Longer-term, the pair remains positive, with the GBP weighed on after BoE’s dovish hike. The Euro has been unable to breach the 0.8860 resistance area on Wednesday. The pair retreated to 0.8800 at the moment of writing, retracing Tuesday’s gains,  and is on track to put an end to a five-day winning streak. The Pound picks up on a quiet market session The Sterling is trimming losses on Wednesday, underpinned by a mild recovery on the GBP/USD, as the US Dollar…

KEY POINTS: Recommended by Zain Vawda Get Your Free Gold Forecast MOST READ: Top 3 FX Themes for 2023: USD, JPY, EuroGold (XAU/USD) FUNDAMENTAL BACKDROPGold continued its decline in European trade to retest the psychological $1800 level. The precious metals continued decline this morning was surprising given a declining US dollar index and retreating US Treasury yields. Yesterday saw gold print a fresh high around $1833 before a rally in the dollar index coupled with technical hurdles pushed price down toward the $1814 level.Developments out of China could be partly to blame for the continued decline in gold prices. China…

Angel Di Bilio/iStock Editorial via Getty Images Southwest Airlines (NYSE:LUV) stock slipped in premarket trading on Wednesday as thousands of cancellations continue. According to FlightAware, Southwest has canceled over 2500 flights on Wednesday, adding to nearly 2700 cancellations on Tuesday and thousands more on Monday. The data provider has accounted for over 2300 cancellations planned for Thursday as well. The levels of cancellations represent between 58% and 64% of scheduled flights per day in the three day span. The outsized cancellation rate contrasts sharply with comparatively negligible rates at major competitors like Delta Air Lines (DAL), United Airlines (UAL), and…

Successful people tend to have an optimistic attitude because when you focus on the positive, you tend to have positive results. Does this hold true in trading? Ask yourself this question, “Out of all the confident people you have ever met in your life, how many of them had a consistently negative outlook or attitude?” I’ll bet the answer is a very small percentage or maybe even none. Instead of feeling bad, sulking in the corner, and eating all the ice cream in the fridge when you’re in the middle of a massive drawdown, be positive and think of how you…

Latest Research Shows Cryptocurrency Payments Widely Accepted Research shows 35% of 2,333 consumers prefer merchants accepting crypto payments.42% of tech-driven consumers buy cryptos for investment purposes while 33% buy them for shopping. is the most popular crypto transaction method followed by . As per the latest research conducted among 2,333 tech-driven consumers, more than 1 in 3 (35%) prefer merchants accepting crypto payments. The research was conducted in collaboration with the crypto-processing platform BitPay.Twenty-six percent of this research population believe they would even consider switching merchants to shops where crypto is accepted. While 1 in every 4 (23%) tech-focussed consumers…

Active and passive investing has been at the forefront of financial debate in recent years. Experts and analysts have strong opinions on the topic but there is no debate that both parties have valid points to consider when tackling this sensitive subject. This article aims to provide the relevant information to equip investors and traders with the correct tools to make informed investment decisions when faced with the active versus passive investing conundrum.What is Active Investing?Active investing is the process by which a portfolio manager selects suitable investments based on the independent valuations in order to outperform a specific benchmark…

The US Dollar is likely to be more stable in 2023 after two years of trending strongly higher. Strategists at Credit Suisse expect further USD weakness in Q1, followed by the development of a broad rangebound environment. Further USD weakness in Q1, followed by a broad range “For the DXY, we look for a test of a cluster of supports in the 102.99/101.99 zone – the March 2020 high, the 50% retracement of the 2021/2022 bull trend and importantly the back of the 2017/2022 five-year bull ‘triangle’ pattern. We then look for the DXY to find an important floor here.”…

POUND STERLING ANALYSIS & TALKING POINTSU.S. housing market data dominates headlines today.Weak economic data adds to lack of price action.Breakout requires stimulus. Recommended by Warren Venketas Get Your Free GBP Forecast GBP FUNDAMENTAL BACKDROPThe British pound has been rather indecisive of late which is to be expected at this time of year with minimal trading volumes and lack of fundamental stimuli. The economic calendar is equally as bare, with no high impact events scheduled for today (see economic calendar below). U.S. housing data will be the focus and with a housing recession being dominating headlines of recent, these metrics will…

Just to provide a bit of context, Ito is also touted to be a potential successor to Kuroda for the top job at the BOJ, and he has previously worked closely with Kuroda together at Japan’s finance ministry and was also Kuroda’s inspiration for adopting the 2% inflation Inflation Inflation is defined as a quantitative measure of the rate in which the average price level of goods and services in an economy or country increases over a period of time. It is the rise in the general level of prices where a given currency effectively buys less than it did…

Roland Magnusson/iStock Editorial via Getty Images Japan’s Ministry of Health, Labour, and Welfare approved AstraZeneca’s (NASDAQ:AZN) immunotherapies Imfinzi and Imjudo to treat certain types of liver and lung cancers and Imfinzi to treat biliary tract and liver cancers. The approvals allow Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) to treat adult patients with unresectable hepatocellular carcinoma (HCC) (a type of liver cancer) and to treat adult patients with unresectable, advanced or recurrent non-small cell lung cancer (NSCLC) in combination with chemotherapy. Imfinzi was also authorized for treating adult patients with unresectable HCC as monotherapy and to treat adult patients with…